Goldberg
Law PC (http://www.Goldberglawpc.com)
announces that it is investigating claims of potential
misrepresentations by INSYS Therapeutics, Inc. (“INSYS” or the
“Company”) (Nasdaq: INSY).
Investors who purchased or otherwise acquired shares between March 3,
2015 and December 2, 2015, are encouraged to contact the firm.
If you purchased or otherwise acquired INSYS shares and would like more
information regarding the investigation, we advise you to contact Michael
Goldberg or Brian Schall,
of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 1404, Marina Del Rey,
CA 90292, at 800-977-7401, to discuss your rights without cost to you.
You can also reach us through the firm’s website at http://www.Goldberglawpc.com,
or by email at info@goldberglawpc.com.
The investigation concerns whether the Company violated Sections 10(b)
and 20(a) of the Securities Exchange Act of 1934. Specifically, the
investigation will focus on whether the Company failed to disclose that:
(i) the Company was engaged in the illegal and improper off-labeling
marketing of Subsys as required to do so by state and federal
regulators; (ii) certain Insys employees—including Defendant Michael L.
Babich, the President and Chief Executive Officer of Insys during much
of the Class Period—were complicit in an illegal kickback scheme
operated for the purpose of increasing prescriptions of Subsys; and
(iii) as a result, the Company’s financial statements were materially
false and misleading at all relevant times.
If you have any questions concerning your legal rights in this case,
please immediately contact Goldberg Law PC at 800-977-7401, or visit our
website at http://www.Goldberglawpc.com,
or email us at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and specializes
in securities class actions and shareholder rights litigation.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160125006646/en/
Copyright Business Wire 2016